Moberg Pharma AB (publ) (MOB.ST)
SEK 11.28
(10.37%)
SEK 11.28
(10.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -33.2 Million | -16.84 Million | -15.29 Million | -29.92 Million | 73.89 Million | 53.81 Million |
| Net Income | -21.09 Million | -20.22 Million | -20.12 Million | -22.93 Million | 64.81 Million | 51.07 Million |
| Depreciation & Amortization | 2.09 Million | 2.58 Million | 2.58 Million | 2.51 Million | 36.92 Million | 38.36 Million |
| Deferred income taxes | -18.66 Million | - | - | - | -10.35 Million | - |
| Stock-based compensation | 2.3 Million | 1.45 Million | 631 Thousand | 1.03 Million | 3.35 Million | 2.32 Million |
| Change in working capital | -12.15 Million | -1.37 Million | 1.84 Million | -8.71 Million | 17.47 Million | 12.02 Million |
| Other non-cash items | 14.29 Million | 717 Thousand | -240 Thousand | -1.81 Million | -36.41 Million | -49.97 Million |
| Investing Cash Flow | -124.11 Million | -68.07 Million | -41.3 Million | -33.49 Million | -83.64 Million | -19.67 Million |
| Investments in PPE | -124.11 Million | -68.07 Million | -31.3 Million | -33.49 Million | -83.64 Million | -19.67 Million |
| Acquisitions | - | - | -9.99 Million | -3.76 Million | 1.43 Billion | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -124.11 Million | -68.07 Million | -31.3 Million | 3.76 Million | -1.43 Billion | 53.79 Million |
| Financing Cash Flow | 92.32 Million | 107.8 Million | 129.97 Million | 27.99 Million | -666 Thousand | 858 Thousand |
| Debt repayment | -2.42 Million | -1.87 Million | -3.46 Million | -5.8 Million | -576.79 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -187 Thousand | - | - | -558.26 Million | -26 Thousand | - |
| Common Stock Issuance | 94.75 Million | 109.68 Million | 133.43 Million | 30.47 Million | 26 Thousand | 947 Thousand |
| Other Financing Activities | -2.42 Million | 107.8 Million | 129.97 Million | 1.11 Billion | 1.15 Billion | -89 Thousand |
| Accounts receivables | 424 Thousand | -210 Thousand | 6.83 Million | -4.17 Million | 19.05 Million | 4.21 Million |
| Accounts payables | -5.46 Million | -1.16 Million | -4.98 Million | -27.63 Million | 6.44 Million | -4.3 Million |
| Inventory | -7.11 Million | 1.16 Million | 4.98 Million | - | 3.82 Million | 12.1 Million |
| Other working capital | -5.46 Million | -1.16 Million | -4.98 Million | 23.09 Million | -11.84 Million | -83 Thousand |
| Cash at beginning of period | 125.55 Million | 102.65 Million | 29.28 Million | 64.7 Million | 119.43 Million | 86.1 Million |
| Cash at end of period | 60.55 Million | 125.55 Million | 102.65 Million | 29.28 Million | 110.78 Million | 119.43 Million |
| Capital Expenditure | -124.11 Million | -68.07 Million | -31.3 Million | -33.49 Million | -83.64 Million | -19.67 Million |
| Effect of forex changes on cash | - | - | - | - | 1.76 Million | -1.66 Million |
| Net cash flow / Change in cash | -64.99 Million | 22.89 Million | 73.37 Million | -35.42 Million | -8.65 Million | 33.33 Million |
| Free Cash Flow | -157.32 Million | -84.91 Million | -46.6 Million | -63.41 Million | -9.75 Million | 34.14 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.04 Million | -7.89 Million | -21.09 Million | -6.44 Million | -7.26 Million | -5.29 Million |
| Depreciation & Amortization | 330 Thousand | 329 Thousand | 2.09 Million | 260 Thousand | 613 Thousand | 613 Thousand |
| Deferred income taxes | - | - | -18.66 Million | 4.18 Million | - | - |
| Stock-based compensation | 1.23 Million | 621 Thousand | 2.3 Million | 625 Thousand | 626 Thousand | 532 Thousand |
| Change in working capital | -5.96 Million | 3.18 Million | -12.15 Million | -1.78 Million | -5.57 Million | -4.22 Million |
| Other non-cash items | 6.15 Million | -803 Thousand | 14.29 Million | -4.18 Million | 127 Thousand | 164 Thousand |
| Investing Cash Flow | -16.79 Million | -17.82 Million | -124.11 Million | -33.21 Million | -33.64 Million | -22.76 Million |
| Investments in PPE | -16.79 Million | -17.82 Million | -124.11 Million | -33.21 Million | -33.64 Million | -22.76 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -16.79 Million | -17.82 Million | -124.11 Million | -33.21 Million | -33.64 Million | -22.76 Million |
| Financing Cash Flow | 313.94 Million | -312 Thousand | 92.32 Million | -386 Thousand | 94.66 Million | -1.61 Million |
| Debt repayment | -434 Thousand | -312 Thousand | -2.42 Million | -118 Thousand | -359 Thousand | -1.61 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -187 Thousand | -187 Thousand | - | - |
| Common Stock Issuance | 314.37 Million | - | 94.75 Million | -268 Thousand | 95.01 Million | - |
| Other Financing Activities | -434 Thousand | - | -2.42 Million | -118 Thousand | -359 Thousand | -1.61 Million |
| Accounts receivables | -3.46 Million | -840 Thousand | 424 Thousand | 778 Thousand | -487 Thousand | 625 Thousand |
| Accounts payables | -4.13 Million | 3.48 Million | -5.46 Million | 4.55 Million | -5.08 Million | -5.13 Million |
| Inventory | 1.62 Million | 536 Thousand | -7.11 Million | -7.11 Million | 5.08 Million | - |
| Other working capital | -4.13 Million | 3.48 Million | -5.46 Million | 4.55 Million | -5.08 Million | 285 Thousand |
| Cash at beginning of period | 38.63 Million | 60.55 Million | 125.55 Million | 101.5 Million | 51.95 Million | 84.54 Million |
| Cash at end of period | 325.95 Million | 38.63 Million | 60.55 Million | 60.55 Million | 101.5 Million | 51.95 Million |
| Capital Expenditure | -16.79 Million | -17.82 Million | -124.11 Million | -33.21 Million | -33.64 Million | -22.76 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 287.32 Million | -21.92 Million | -64.99 Million | -40.94 Million | 49.55 Million | -32.58 Million |
| Free Cash Flow | -26.61 Million | -21.61 Million | -157.32 Million | -40.56 Million | -45.1 Million | -30.97 Million |
SALEM
005725
NXNN
CEVI
300793
TELHF